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1488Background: We hypothesize that minimally invasive valve surgery in patients with chronic kidney disease
(CKD) is superior to a conventional median sternotomy.
Methods: We retrospectively analyzed 1945 consecutive patients who underwent isolated valve surgery.
Included were patients with CKD stages 2 to 5. In-hospital mortality, composite complication rates, and inten-
sive care unit and total hospital lengths of stay of those who underwent a minimally invasive approach were
compared with those who underwent a standard median sternotomy. Resource use was approximated based
on intensive care unit and total hospital lengths of stay.
Results: There were 688 patients identified; 510 (74%) underwent minimally invasive surgery, and 178 (26%)
underwent a median sternotomy. There was no significant difference in mortality. Minimally invasive surgery
was associated with fewer composite complications (33.1% vs 49.4%; odds ratio, 0.5; P .001), shorter inten-
sive care unit (48 [interquartile range {IQR}, 33-74] hours vs 71 [IQR, 42-96] hours; P<.01), and hospital (8
[IQR, 6-9] days vs 10 [IQR, 8-15] days; P<.001) lengths of stay, and a lower incidence of acute kidney injury
(8% vs 14.7%; odds ratio, 0.5; P ¼ .01), compared with median sternotomy. In a multivariable analysis, mini-
mally invasive surgery was associated with a 60% reduction in the risk of development of postoperative acute
kidney injury.
Conclusions: In patients with CKD undergoing isolated valve surgery, minimally invasive valve surgery is
associated with reduced postoperative complications and lower resource use. (J Thorac Cardiovasc Surg
2013;146:1488-93)According to data published by the National Institutes of
Health, more than 10% of the US population is diagnosed
with chronic kidney disease (CKD), and nearly 113,000 pa-
tients will progress to end-stage renal disease each year.1
Cardiovascular disease is one of the leading causes of
morbidity and mortality in this population, and the chronic
inflammation, endothelial dysfunction, and metabolic dis-
turbances seen in the progression ofCKDhave been strongly
associatedwith the development of valvular heart disease.2,3
Patients undergoing cardiac surgery have a 3.3-fold
increased risk of developing acute kidney injury (AKI),
with a 2.3-fold increased risk of requiring dialysis, and in
the past decade, the associatedmortality ofAKI after cardiac
surgery has increased from 30% to 47%.4 In the setting of
CKD, these effects are augmented, with an increased
incidence of CKD progression and late-term mortality.5e Columbia University Division of Cardiology at Mount Sinai Heart
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The Journal of Thoracic and Cardiovascular SurWhen compared with a median sternotomy approach, the
reported benefits of minimally invasive valve surgery
include decreased blood loss, reduced incidence of postop-
erative atrial fibrillation, shorter intensive care unit and
hospital length of stays, and faster patient recovery.6-11
These findings have also been reported in such high-risk
groups as elderly patients, obese patients, and those
undergoing reoperative valve surgery, leading to an
increased acceptance of minimally invasive surgery as a
viable option to the standard median sternotomy
approach.12-15 The purpose of our study was to analyze the
impact of minimally invasive valve surgery on the incidence
of postoperative AKI and postoperative complications in
patients with stage 2 to 5 CKD. We analyzed the outcomes
of patients who underwent valve surgery via a minimally
invasive approach, and compared them with a cohort who
underwent median sternotomy valve surgery.METHODS
After obtaining approval from the Mount Sinai Medical Center Institu-
tional Review Board, we retrospectively evaluated 1945 valve operations
performed at our institution between January 1, 2005, and December 7,
2011, to identify patients with stage 2 to 5 CKD who underwent isolated
mitral or aortic valve surgery. Excluded were patients who had concomitant
coronary artery bypass graft surgery, surgery on another valve and/or
ascending aorta, a history of cardiac surgery, infective endocarditis,
emergency surgery, and stage 1 CKD. The estimated glomerular filtration
rate (eGFR) was calculated using the modification of diet in renalgery c December 2013
Abbreviations and Acronyms
AKI ¼ acute kidney injury
CKD ¼ chronic kidney disease
eGFR ¼ estimated glomerular filtration rate
IQR ¼ interquartile range
RIFLE ¼ Risk, Injury, Failure, Loss, End-stage
renal disease
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Mdisease equation: eGFR (mL/min per 1.73 m2) ¼ 186 3 (serum
creatinine)1.154 3 (age)0.203 3 (0.742 if female) 3 (1.21 if African
American). Patients were grouped according to eGFR and the National
Kidney Foundation stages for CKD, as follows: stage 1, 90 mL/min per
m2 or higher; stage 2, 60 to 89 mL/min per m2; stage 3, 30 to 59 mL/min
per m2; stage 4, 15 to 29 mL/min per m2; and stage 5, less than 15 mL/
min per m2 or patients undergoing dialysis.16 The median sternotomy
surgery was performed by 6 different surgeons, whereas the minimally
invasive surgery was performed by a single surgeon.
All patients underwent left heart catheterization and echocardiography
to evaluate their valvular lesions, and all operative reports and echocardio-
grams were reviewed. Postoperative composite complicationswere defined
as the development of AKI, prolonged ventilation (>24 hours), reintuba-
tion, atrial fibrillation, deep wound infection, pneumonia, sepsis, bleeding
requiring reexploration, stroke, or death. In-hospital mortality was defined
as death at any time after the operation if the patient was not discharged
from the hospital alive. The surgical technique time was evaluated by
comparing the aortic crossclamp with the total cardiopulmonary bypass
times. The definitions and variables selected were based on the Society
of Thoracic Surgeons Database definitions. Postoperative AKI was further
analyzed by the Risk, Injury, Failure, Loss, End-stage renal disease
(RIFLE) classification system, proposed by the Acute Dialysis Quality
Initiative group.16 This classification divides the patients with AKI into 5
categories: (1) risk, GFR decrease of less than 25%, serum creatinine
increase of 1.5 times, or urine production of less than 0.5 mL/kg per
hour for 6 hours; (2) injury, GFR decrease of greater than 50% and
doubling of creatinine or urine production by less than 0.5 mL/kg per
hour for 12 hours; (3) failure, GFR decrease of greater than 75%, tripling
of creatinine or creatinine increase greater than 355 mmol/L (with an
increase of >44 mmol/L [>4 mg/dL]), or urine output lower than
0.3 mL/kg per hour for 24 hours; (4) loss, persistent AKI or complete
loss of kidney function for more than 4 weeks; and (5) end-stage renal
disease, need for renal replacement therapy for more than 3 months.
Technique for Minimally Invasive Valve Surgery
A femoral or axillary platform was used to establish cardiopulmonary
bypass. The femoral/axillary artery was cannulated with a 15-19 Fr arterial
cannula (Biomedicus; Medtronic, Minneapolis, Minn), and the femoral
vein was cannulated with a 25 Fr venous cannula (Biomedicus). Transeso-
phageal echocardiography was used to aid in the placement of the venous
cannula in the superior vena cava.
For the mitral valve procedures, a 5- to 6-cm skin incision was made in
the fourth to fifth intercostal space lateral to the anterior axillary line. The
mitral valve was accessed through the Waterston groove, then through the
atrial septum into the left atrium. Mitral valve repair or replacements were
performed in the standard manner. For aortic valve procedures, a 5- to 6-cm
right transverse skin incision was made 1 cm lateral to the sternum over the
second to third intercostal space. In all aortic valve procedures, the second
or third costochondral cartilage was transected to allow adequate exposure
of the aorta and avoid fracturing the rib. At the completion of the operation,
the rib was reattached to the sternum with a 1-cm metal plate (Synthes,
West Chester, Pa), and a fiber wire was placed in a figure-of-eight manner.The Journal of Thoracic and CarA left ventricular vent was inserted into the left ventricle via a purse string
suture in the right superior pulmonary vein, and a retrograde cardioplegia
cannula was inserted via the right atrial appendage using transesophageal
echocardiographic guidance. A transverse aortotomy was performed to
expose the aortic valve, and valve replacement was performed under direct
vision using standard techniques.
For all procedures, cardiopulmonary bypass was initiated at 32C to
36C using a closed-membrane oxygenator and roller pump. Venous
drainage was augmented with vacuum assistance, applying negative pres-
sures of 30 to 70mmHg as needed to decompress the right side of the heart.
Transincisional direct aortic crossclamping was performed using a flexible
and retractable shaft crossclamp (Novare Surgical Systems, Cupertino,
Calif). One dose of antegrade cold blood cardioplegia was given to estab-
lish electromechanical arrest of the heart. Thereafter, retrograde cold blood
cardioplegia was given throughout the procedure at 20- to 25-minute inter-
vals. If retrograde cardioplegia was not possible, a cardioplegia cannula
was left in the ascending aorta, or direct cannulation of the coronary ostia
was performed to deliver antegrade cardioplegia. Carbon dioxide was
infused into the operative field during the entire procedure. Removal of
air from the heart was performed with a venting needle in the root of the
aorta and under transesophageal echocardiographic guidance. After
discontinuing cardiopulmonary bypass and administering protamine,
decannulation was performed. A single chest tube was left in the pleural
space. For pain relief, all patients had an On-Q pain relief system inserted
(I-Flow Corporation, Lake Forest, Calif). Two catheters were placed in the
interspace to deliver 0.25% bupivacaine for 72 hours. The thoracotomy
incision was closed in the routine manner.
Statistical Analyses
Patient demographics and operative data were expressed as the mean
1 SD, or median and interquartile range (IQR, or 25%-75%), as appro-
priate. Continuous variables with a normal distribution were compared
using an independent Student t test and correlation coefficient, when appro-
priate, whereas variables that did not exhibit a normal distribution were
compared using a Mann-Whitney U test. A c2, Pearson c2, or Fisher exact
test was used to compare dichotomous variables, when appropriate.
A univariable analysis was performed for baseline characteristics, surgical
procedural variables, postoperative outcomes, and other known risk factors
that could influence the clinical outcomes. The variables with P  .2 were
included in a binary logistic regression analysis to determine their indepen-
dent effects. The model was assessed by the Hosmer-Lemeshow goodness-
of-fit test. All statistical analyses were performed with the assistance of a
statistician using SPSS, version 17 (SPSS Inc, Chicago, Ill).RESULTS
A total of 688 patients were identified. Of these patients,
510 had valve surgery via a minimally invasive approach,
and 178 underwent a median sternotomy. The patients in
the minimally invasive group were older (71.3  11.6 vs
67.8  12 years; P ¼ .001), whereas those in the median
sternotomy group had a higher body mass index (27.3 
4.8 vs 28.5  5.8 kg/m2; P ¼ .03) and greater incidence
of stage 5 CKD (4% vs 1%; P¼ .008). There were no other
differences between the 2 groups regarding baseline charac-
teristics (Table 1).
In the entire cohort of patients (excluding those with
stage 5 CKD at baseline), 66 developed AKI and 608 did
not. Those who developed AKI were significantly older,
obese, had a greater incidence of median sternotomy,
and had a higher baseline mean pulmonary arterydiovascular Surgery c Volume 146, Number 6 1489
TABLE 2. Baseline characteristics in patients with postoperative
acute kidney injury versus no acute kidney injury (based on 674
patients with CKD stages 2-4)
Variable
Acute
kidney injury
(n ¼ 66)
No acute
kidney injury
(n ¼ 608)
P
value
Age, y 72  11 70  11 .03
Male sex 30 (45.4) 318 (52.5) .41
Body mass index, kg/m2 29  5.5 27  5.1 .04
African American 2 (3) 25 (4) .49
Diabetes mellitus 22 (34) 147 (24) .13
Hypertension 63 (96) 527 (87) .06
Previous myocardial infarction 10 (15) 106 (17) .8
Chronic obstructive pulmonary
disease
17 (26.2) 153 (25.2) .98
Peripheral vascular disease 8 (12) 99 (16) .24
Preoperative GFR, mL/min per m2 64.6  17 65.5  14.7 .63
Preoperative serum creatinine,
mg/dL
1.12  0.44 1.1  0.3 .57
Stage 2 CKD (GFR,
60-89 mL/min per 1.73 m2
40 (61) 397 (65) .53
Stage 3 CKD (GFR,
30-59 mL/min per 1.73 m2)
23 (34) 201 (33) .87
Stage 4 CKD (GFR,
15-29 mL/min per 1.73 m2)
3 (5) 10 (2) .12
Ejection fraction,%* 55 (40-64) 58 (50-60) .71
Pulmonary artery pressure, mm Hg 30.5  9.5 27.1  9.2 .003
Hematocrit,% 38.5  2.9 39  4.5 .47
Median sternotomy surgery 26 (40) 145 (24) .009
Aortic crossclamp time, min 82  33 78  29 .26
Cardiopulmonary bypass time, min 113  39 106  35 .13
Data are given as mean  SD or number (%) and are based on the Risk, Injury, Fail-
ure, Loss, End-stage renal disease (RIFLE) definition. Excluded in the analysis were
patients with stage 5 CKD. CKD, Chronic kidney disease; GFR, glomerular filtration
rate. *Data are given as median (interquartile range).
TABLE 1. Baseline characteristics of the minimally invasive versus
median sternotomy groups
Variable
Minimally
invasive
(n ¼ 510)
Median
sternotomy
(n ¼ 178)
P
value
Age, y 71.3  11.6 67.8  12 .001
Male sex 258 (51) 99 (56) .21
Body mass index, kg/m2 27.3  4.8 28.5  5.8 .03
African American race 24 (5) 7 (4) .84
Diabetes mellitus 130 (26) 45 (25) .99
Hypertension 393 (89) 151 (86) .63
Previous myocardial infarction 95 (19) 26 (15) .29
Chronic obstructive pulmonary disease 125 (25) 50 (30) .26
Peripheral vascular disease 82 (16) 27 (15) .86
Preoperative GFR 64.4  16 63.9  18 .53
Preoperative creatinine 1.16  0.36 1.3  0.29 .1
Stage 2 CKD (GFR, 60-89 mL/min per
1.73 m2)
325 (64) 112 (63) .95
Stage 3 CKD (GFR, 30-59 mL/min per
1.73 m2)
167 (33) 57 (32) .98
Stage 4 CKD (GFR, 15-29 mL/min per
1.73 m2)
11 (2) 2 (1) .26
Stage 5 CKD (GFR,<15 mL/min per
1.73 m2)
7 (1) 7 (4) .008
Ejection fraction,%* 58 (50-60) 55 (43-60) .09
Pulmonary artery pressure, mm Hg 27  9 28  9 .58
Hematocrit,% 38.8  4.8 39.4  4.5 .1
Predicted risk for morbidity and
mortality,%
19  9 18  10 .14
Predicted risk for acute renal failure,% 5  4 4  3 .16
Data are given as mean  SD or number (%). GFR, Glomerular filtration rate; CKD,
chronic kidney disease. *Data are given as median (interquartile range).
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M pressure. However, the aortic crossclamp and cardiopulmo-
nary bypass times did not differ between the 2 groups
(Table 2).
The valve surgery consisted of 323 aortic valve replace-
ments (236 [46%] minimally invasive and 87 [49%]
median sternotomy; P¼ .6) and 365 mitral valve operations
(274 [54%] minimally invasive and 91 [51%] median ster-
notomy; P ¼ .6). Of the mitral valve operations, there were
110 (40%) versus 31 (34%) replacements (P ¼ .36), and
164 (60%) versus 60 (66%) repairs (P ¼ .36), in the mini-
mally invasive versus median sternotomy groups, respec-
tively. The mean aortic crossclamp time was 83  27
versus 63 30 minutes (P<.001), and the mean cardiopul-
monary bypass time was 113  32 versus 87  38 minutes
(P < .001), for the minimally invasive and the median
sternotomy groups, respectively. The patients undergoing
minimally invasive surgery had significantly less need for
packed red blood cell and fresh-frozen plasma transfusions,
when compared with those who had a median sternotomy.
No difference was noted in the in-hospital mortality
between the minimally invasive and the median sternotomy
groups (1% vs 3%; P ¼ .17). However, composite post-
operative complications were significantly less in the1490 The Journal of Thoracic and Cardiovascular Surminimally invasive group (33% vs 49%; P<.001), driven
by a decreased incidence of AKI, atrial fibrillation, pro-
longed ventilation, reintubation, and sepsis. The intensive
care unit and total hospital lengths of stay were 48 (IQR,
33-74) hours versus 71 (IQR, 42-96) hours (P< .01) and
8 (IQR, 6-9) days versus 10 (IQR, 8-15) days (P< .001)
for the minimally invasive and the median sternotomy
groups, respectively (Table 3, Figure 1).
Among the patients who developed postoperative AKI,
when compared with those who did not develop AKI, there
was a higher in-hospital mortality (8% vs 1%; P<.001),
and composite postoperative complications (64% vs
34%; P<.001), with a significant increase in the incidence
of pneumonia, need of reintubation, sepsis, deep wound
infection, and prolonged ventilation (Table 4, Figure 2).
Furthermore, the patients with postoperative AKI had a me-
dian intensive care unit length of stay of 116 (IQR, 60-317)
hours versus 49 (IQR, 46-77) hours (P<.001) and a median
total hospital length of stay of 14 (IQR, 10-18) days versus 8
(IQR, 6-10) days (P<.001).gery c December 2013
TABLE 3. Operative and postoperative outcomes in patients
undergoing minimally invasive versus median sternotomy valve
surgery
Variable
Minimally
invasive
(n ¼ 510)
Median
sternotomy
(n ¼ 178)
P
value
Aortic valve replacement, No. 236 87 .6
Aortic crossclamp time, min 84  28 68  33 <.001
Cardiopulmonary bypass time, min 111  35 88  24 <.001
Mitral valve replacement, No. 110 31 .36
Aortic crossclamp time, min 71  28 67  36 .4
Cardiopulmonary bypass time, min 100  34 96  43 .6
Mitral valve repair, No. 164 60 .36
Aortic crossclamp time, min 74  30 53  18 <.001
Cardiopulmonary bypass time, min 104  37 77  26 <.001
Transfusion of packed red
blood cells, U*
2 (1-3) 4 (2-5) <.001
Transfusion of fresh-frozen
plasma, U*
0.2 (0-3) 2 (0-4) <.001
Acute kidney injury (based on STS) 11 (2) 11 (7) .01
Acute kidney injury (based on RIFLE) 40 (8) 25 (15) .01
Stage 1 (risk) 26 (5) 13 (8) .32
Stage 2 (injury) 11 (2) 9 (5) .31
Stage 3 (failure) 3 (1) 3 (2) .17
Dialysis 8 (2) 3 (2) .99
In-hospital mortality 7 (1) 6 (3) .17
Composite complications 169 (33) 88 (49) <.001
Atrial fibrillation 95 (19) 48 (27) .02
Pneumonia 22 (4) 7 (4) .99
Reintubation 30 (6) 21 (13) .004
Stroke 4 (1) 4 (2) .24
Sepsis 8 (2) 10 (6) .008
Wound infection 2 (0.4) 2 (1) .59
Prolonged ventilation 86 (17) 50 (28) .002
Bleeding requiring reoperation 12 (2) 5 (3) .95
Postoperative creatinine (peak), mg/dL 1.28  0.6 1.3  0.6 .47
Intensive care unit length of stay, h* 48 (33-74) 71 (42-96) <.01
Hospital length of stay, d* 8 (6-9) 10 (8-15) <.001
Data are given as mean  SD or number (%). STS, Society of Thoracic Surgeons;
RIFLE, Risk, Injury, Failure, Loss, End-stage renal disease. *Data are given as
median (interquartile range).
FIGURE 1. Postoperative outcomes in patients undergoing minimally
invasive versus median sternotomy valve surgery. The asterisk denotes sta-
tistically significant differences between groups. AKI, Acute kidney injury;
STS, Society of Thoracic Surgeons; RIFLE, Risk, Injury, Failure, Loss,
End-stage renal disease; Sternotomy, median sternotomy;Mini, minimally
invasive.
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MMultivariable analysis revealed that minimally invasive
surgery was associated with a reduction in postoperative
AKI, whereas mean pulmonary artery pressure, age older
than 75 years, cardiopulmonary bypass time greater than
100 minutes, and postoperative sepsis were associated
with an increased incidence of AKI (Table 5).DISCUSSION
Because of an increased incidence of cardiovascular
comorbidities and pathophysiological changes associated
with chronic uremia, patients with CKD undergoing cardiac
surgery have a significant risk of perioperative complica-
tions. Preoperative renal dysfunction has been an indepen-
dent predictor of in-hospital mortality and poor late-termThe Journal of Thoracic and Carsurvival, with a nearly 5-fold increased mortality among
patients undergoing valve surgery.17-19 Furthermore, the
development of AKI after cardiac surgery is associated
with a significant increase in healthcare costs, with small
increases in serum creatinine (>0.3 mg/dL) adding nearly
$10,000 to the cost of hospitalization.20 A minimally
invasive approach to valve surgery has emerged as a safe
and feasible alternative to standard median sternotomy
surgery in such high-risk populations as elderly
patients, obese patients, and those with a history of sterno-
tomy.12-15 Our hypothesis was that patients with CKD
undergoing isolated valve surgery are at a high risk for
perioperative morbidity and mortality and, thus, would
benefit from a minimally invasive approach.
In the present study, despite significantly longer aortic
crossclamp and cardiopulmonary bypass times in the
minimally invasive group, we observed an overall 60%
reduction in the risk of development of postoperative
AKI. In the entire cohort, the predictors of AKI included
an increased mean pulmonary artery pressure, an age of
75 years or older, a cardiopulmonary bypass time of greater
than 100 minutes, and postoperative sepsis. The develop-
ment of AKI was associated with an increased mortality,
an increased incidence of infections, the need for reintu-
bation, prolonged ventilation, and significantly longer
intensive care unit and hospital lengths of stay. Therefore,
minimally invasive valve surgery, by reducing the incidence
of AKI, may have reduced the incidence of these complica-
tions, and shortened the intensive care unit and hospital
lengths of stay.
The data comparing postoperative renal injury between
less invasive valve surgery and standard median sternotomy
surgery are limited. McCreath and colleagues21 analyzed a
total of 650 patients who underwent mitral valve surgery viadiovascular Surgery c Volume 146, Number 6 1491
TABLE 4. Postoperative outcomes in patients with acute kidney
injury versus no acute kidney injury
Variable
Acute
kidney injury
(n ¼ 66)
No acute
kidney injury
(n ¼ 608)
P
value
In-hospital mortality 5 (8) 7 (1) <.001
Composite complications 42 (64) 204 (34) <.001
Atrial fibrillation 16 (24) 123 (20) .54
Pneumonia 13 (20) 15 (3) <.001
Reintubation 5 (8) 7 (1) <.001
Stroke 1 (2) 6 (1) 1
Sepsis 10 (15) 8 (1) <.001
Wound infection 2 (3) 2 (0.3) .04
Prolonged ventilation 31 (47) 94 (15) <.001
Bleeding requiring reoperation 4 (6) 13 (2) .12
Postoperative creatinine
(peak), mg/dL
2.24  1 1.17  0.38 <.001
Intensive care unit length
of stay, h*
116 (60-317) 49 (46-77) <.001
Hospital length of stay, d* 14 (10-18) 8 (6-10) <.001
Data are given as number (%) or mean  SD. Excluded in the analysis were patients
with stage 5 chronic kidney disease. *Data are given as median (interquartile range).
TABLE 5. Multivariable predictors of postoperative acute kidney
injury (based on RIFLE criteria)
Variables Odds Ratio 95% CI P value
Minimally invasive valve surgery 0.4 0.19-0.88 .02
Mean pulmonary artery pressure 1.03 1.00-1.06 .03
Aged 75 y 1.9 1.05-2.07 .03
Cardiopulmonary bypass time>100 min 2.4 1.2-4.6 .007
Postoperative sepsis 6.8 1.9-23 .003
Chronic kidney disease stage, diabetes mellitus, hematocrit lower than 35%, units of
packed red blood cells (transfusion), body mass index greater than 35 kg/m2, and
African American race were entered into the multivariable analysis, and were not
statistically significant. RIFLE, Risk, Injury, Failure, Loss, End-stage renal disease;
CI, confidence interval.
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Mport access (n ¼ 467) or median sternotomy (n ¼ 183) and
found a significant reduction in postoperative renal injury
and a trend toward reduced major adverse events among
the port-access group. Similar results were reported by An-
tonic and Gersak,22 who compared 96 patients undergoing
port-access mitral valve surgery with 102 patients undergo-
ing a median sternotomy approach; they found that patients
in the median sternotomy group had lower postoperative
creatinine clearance and higher incidence of postoperative
renal impairment. The present study validates the reported
renoprotective benefits of a minimally invasive approach,
and demonstrates the safety and feasibility of this technique
in patients with CKD. We hypothesize that the renoprotec-
tive benefits of minimally invasive valve surgery in patients
with CKD may be driven by 2 main factors. First, cardiac
surgery is a powerful trigger of immune system activation,FIGURE 2. Postoperative outcomes in patients with acute kidney injury
(AKI) versus no AKI. The asterisk denotes statistically significant differ-
ences between groups.
1492 The Journal of Thoracic and Cardiovascular Surleading to the up-regulation of cellular immune factors and
the development of systemic immune inflammatory syn-
drome, which increases the risk of renal injury and failure.23
By avoiding the surgical trauma and morbidity associated
with a median sternotomy, a minimally invasive approach
allows for a reduction in postoperative inflammation and
enhanced recovery, which may provide renoprotective ef-
fects in high-risk populations, such as patients with CKD.
Second, because of structural and biochemical alterations
that develop in stored erythrocytes, transfusion of packed
red blood cells can lead to activation of the inflammatory
cascade and impaired oxygen delivery in susceptible popu-
lations, which are known contributors of renal dysfunc-
tion.24 In patients undergoing cardiac surgery, transfusion
of packed red blood cells is associated with increased risk
of postoperative complications, early and late mortality,
and hospital length of stay and costs.25 Therefore, it is plau-
sible that, by decreasing the incidence of blood transfusions
and bleeding complications with minimally invasive valve
surgery, postoperative renal injury and its associated
complications may be reduced. One of the postoperative
complications that was significantly reduced with the mini-
mally invasive approach was the incidence of atrial fibrilla-
tion. We hypothesize that this reduction in atrial fibrillation
may also be because of the decreased trauma leading to a
reduction in inflammation.9 This reduction in the incidence
of postoperative arrhythmias, along with the reduction in
the perioperative morbidity and in the intensive care unit
and hospital lengths of stays, likely leads to a reduction in
resource use.
The main limitation of our study is that it is a retrospec-
tive, single-center study. The surgical approaches were
performed by 2 different teams of surgeons, which intro-
duces a potential uncontrollable confounder. Furthermore,
all minimally invasive operations were performed by a sin-
gle surgeon (J.L.). Finally, the comparison of the surgical
techniques was limited to in-hospital outcomes.
In conclusion, our study demonstrates the safety and
feasibility of minimally invasive valve surgery in patients
with CKD, which is associated with decreased postopera-
tive complications, faster recovery, and reduced resourcegery c December 2013
Valdez et al Perioperative Managementuse. This approach should be considered as an alternative to
standard median sternotomy valve surgery in this high-risk
population.References
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